Life science research tools market size, growth and trends ( )
|
|
- Shannon Roberts
- 6 years ago
- Views:
Transcription
1 Life science research tools market size, growth and trends ( ) April, nd edition Information contained in this market report is believed to be reliable at the time of publication. DeciBio is not soliciting any action based on the information contained in this report. See appendix section for complete disclosures. DeciBio LLC 1428 Kelton Ave Suite 201 Los Angeles, CA Phone: info@decibio.com
2 Agenda Introduction Executive summary Pure genomics tools Pure proteomics tools Cell biology tools Other analytical technologies Other supplies and technologies Appendix 2
3 Given the current macroeconomic headwinds, DeciBio forecasts that the LS research tools market will grow at ~4% p.a. in the next 5 years Online abstract This report provides an overview of the life sciences research tools market from 2006 to Life sciences research tools companies offer instruments, reagents and services to scientists in academic, BioPharma and applied market laboratories. Top vendors include Agilent, Bio-Rad, EMD Millipore, Life Technologies (Invitrogen / Applied Biosystems), Roche, Sigma-Aldrich and Thermo Fisher; smaller emerging players are highlighted as well (e.g., genomics players [Fluidigm, Raindance, Oxford Nanopore, NABSys, GnuBio]). Segmenting the market by technology, we estimate that the life science research tools market reached $37.4B in 2011, and is expected to grow ~4% p.a. in the next 5 years. Many reports on individual technologies report bullish growth rates of 5%-20% for Academic, BioPharma and Applied market customers (and excluding in vitro diagnostics). While our analysis confirms that applied market might experience double digit growth for many technologies, current market size estimates for these customers do not support an overall market growth of 10%+ for the overall life science research tools sector. This is especially true in light of the current global economic slowdown (including in India and China) and continued sovereign-debt crisis in Europe. A review of public fillings and guidance from the top players in this space as well as an analysis of the funding reality in Academia and BioPharma confirms this outlook. This report evaluates which technologies are expected to capture and loose market share in this mid-single digit growth rate market. In this second edition, we updated our analysis to reflect the most current market sales and trends in 5 broad segments: 1) Pure genomics technologies: qpcr, next generation sequencing (NGS) / third generation sequencing (3GS), microarrays, PCR, CE sequencing, molecular biology tools, digital PCR; 2) Pure proteomics technologies: protein isolation and analysis, ELISA, protein production, western blots and protein microarrays; 3) Cell biology technologies: discovery services, basic cell biology reagents, flow cytometry, transfection and electroporation, media and sera, microscopy, cell culture equipment, whole cell analysis, cells and tissues, high content imaging; 4) Other analytical technologies: liquid chromatography, mass spectroscopy, structural analysis methods, in vivo study, spectroscopy, multiplex technologies, label free technologies; 5) Other supplies and technologies: lab supplies and disposables, glassware, automation, sample preparation, LIMS, magnetic beads. For each of these 35 subsegments, we present an analysis detailing sales of instruments and reagents for 2006, 2011 and In addition, we detail market drivers and moderators, market trends, a high level end-customer breakdown (Academic, BioPharma and Applied markets customers) and key competitors. Many of these technologies are increasingly used for clinical diagnostics purposes. Therefore, we briefly cover the size, growth and trends of the in vitro diagnostics and molecular diagnostics markets. All data are based on manufacturer sales as publically reported, and interviews with life sciences experts in academic, BioPharma and applied market laboratories. 3
4 This report is divided in the following sections Table of contents Introduction 1 Agenda 2 Abstract 3 Table of contents 4 2 nd edition: what s new? 5 Included/excluded technologies 6 Definition (product types) 7 Definition (end-customer types) 8 Methodology 9 Technology timeline 10 Executive summary 11 LS market by category 12 LS market by geography 13 LS market by end-customer 14 LS market by product type 15 R&D funding trends 16 LS players strategic bets 17 LS players and operational excellence 18 Pure genomics tools 19 LS genomics market by technology 20 qpcr 21 Microarrays 22 NGS / 3GS 23 PCR 24 CE sequencing 25 Molecular biology 26 Digital PCR 27 Pure proteomics tools 28 LS proteomics market by technology 29 Protein isolation 30 ELISA 31 Protein production 32 Western blots 33 Protein microarrays 34 Cell biology tools 35 LS Cell biology tools market by technology 36 Discovery services 37 Basic cell biology reagents 38 Flow cytometry 39 Transfection and electroporation 40 Media and sera 41 Microscopy and automation 42 Cell culture equipment 43 Whole cell imaging 44 Cells and tissues 45 High content imaging 46 Other analytical tools 47 LS analytical tools by technology 48 Liquid chromatography 49 Mass spectroscopy 50 Structural analysis 51 Other analytical tools (continued) In vivo study 52 Spectroscopy 53 Multiplex technologies 54 Label free technologies 55 Lab supplies and disposables 56 Overall LS supplies market by technology 57 Basic supplied and disposables 58 Glassware 59 Liquid handling and automation 60 Sample preparation 61 LIMS 62 Magnetic beads 63 Appendix 64 Positioning of key players 65 Revenue guidance from key players 66 NIH funding analysis 67 IVD market 68 MDx market 69 CE instrument decommission 70 NGS market by product type 71 Abbreviations 72 Related DeciBio reports 73 Disclosure 74 4
5 2 nd edition: What s new? Updated content Updated numbers* Incorporated the latest trends in the life science research tools market Added 8 new supplies & technologies to this market: Structural analysis technologies (electron microscopy, NMR and X-ray systems) Spectroscopy Label free technologies Glassware Liquid handling and automation LIMS Added 19 pages, primarily with new analysis, and a description of our methodology and classification Expanded our analysis of key players in this space Updated numbers Updated all market numbers for 2011 market size based on secondary research and latest trends Market growth rate generally adjusted downward given increased focus on funding sources (and economic backdrop [e.g., in Europe]) during our interview campaign Estimated instrument / reagent revenue contribution for 3 technologies based on interviewee feedback Liquid chromatography Mass spectrometry in vivo analysis Reassessed market trends for: NGS in light of recent developments (e.g., $1,000 genome) dpcr given increased visibility of market players and difficulty for the opportunity to materialize (due in part to the lack of clear applications); resulted in decreased overall opportunity size Cell-based discovery services given continued aggressive outsourcing from BioPharma; resulted in increased growth rate estimates Adjusted market size and growth for some markets Microarrays: given identified niche opportunities ELISA: Decreased market size 2010/11 market size (~20%) due to identified analysis bias; accelerated growth due to faster than expected adoption of multiplex ELISA Mass spectrometry: Adjusted market size, given expected use from interviewee feedback Sample preparation: Decreased market growth, given underperformance of market leader (Qiagen) Refined instrument/reagent revenue contributions for some technologies qpcr Laboratory supplies Transfection and electroporation Cell culture equipment * Most significant changes only; additional adjustments have been made based on primary and secondary research data analysis 5
6 This report assesses the WW market size, growth and trends of the life sciences (LS) research tools space; it includes and excludes the following technologies Technologies included* Pure genomic tools qpcr Microarrays Next generation sequencing (NGS) / Third generation sequencing (3GS) PCR CE Sequencing Molecular biology Digital PCR Pure proteomic tools Protein isolation and analysis Protein production ELISA Western blots Protein microarrays Cell biology tools Discovery services Basic cell biology reagents Flow cytometry Transfection and electroporation Media and sera Microscopy Cell culture equipment and plasticware Whole cell imaging Cells and tissues High content imaging (HCI) Other analytical technologies and sample preparation** Liquid chromatography Mass spectroscopy Structural analysis in vivo study Spectroscopy Multiplex technologies Label free technologies Lab supplies and disposables Basic supplies and disposables Glassware Liquid handling and automation Sample preparation LIMS Magnetic beads Technologies excluded In vitro diagnostics Point-of care tests Clinical chemistry Immunoassays / Radioimmunoassays Hematology** / Coagulation assays Microbiology Molecular diagnostics Medical tools and safety Hospital equipment Surgical tools / Safety devices Blood collection products Other life science technologies Synthetic biology (including nucleic acid synthesis) Electrophysiology and patch clamp Single cell analysis Other niche markets*** Combinatorial chemistry Medical devices Source: * Ordered by estimated 2011 market size ** Some of these tools can be used to study both genomics and proteomics *** Small markets such as laser capture microscopy, digital barcoded arrays (i.e., Nanostring) DeciBio analysis 6
7 Market sizes for each of the 35 technologies are reported as instrument or reagent revenues Product types Instruments (Instruments, service contract and software) Instruments include systems and platforms used for sample preparation or analysis, and that typically require a source of energy (e.g., 110V / 220V, battery)* Example instruments include sequencers, mass spectrometers, PCR thermal cyclers or ph meters Many users purchase a service contract (or annual maintenance agreement) to insure the instrument and guarantee timely repair when necessary Service contracts typically vary from 8-15% of instrument purchase price (per year) Software run complex instruments often required to be connected to a computer for operation and data analysis Reagents (Reagents, consumables and services) Reagents and kits are products that are used (in combination or not with an instrument) in order to analyze a sample Example reagents include PCR primers, antibodies or cells Consumables are products used in order to conduct the experiment, but that are not necessarily directly involved in the analytical process Example consumables include pipette tips, gloves or glassware Services are experiments conducted for a lab by a life science research tools manufacturer (not another laboratory, core facility or CRO) Example services include sequencing services from Complete Genomics, bioproduction services from Life Technologies, discovery services from Millipore Source: * Exceptions exist (e.g., pipettes, some cell counters) DeciBio analysis 7
8 Customers were separated in 3 groups: academic and government labs, BioPharma, and applied markets Customer types Academic and government BioPharma* Applied markets Definition Non-profit customers and centers relying on government funding, primarily from the NIH in the U.S.** Basic and translational research Incentive to innovate: High (very early technology adopter) For profit organizations developing drugs for treatment of diseases such as cancer or Alzheimer s Preclinical research (and some use during clinical trials) Incentive to innovate: Moderate to high (early technology adopter) For profit or government fundedinstitutions and laboratories Testing (and some basic research [e.g., in AgBio]) Incentive to innovate: Moderate (late technology adopter****) Example customers Yale U. professor (academia) USCD associate professor (academia) Missouri U. core lab (academia) NIH post-doctoral fellow (government) Pfizer (large pharma) Novartis (large pharma) Amgen (large biotech) Actellion (small pharma) Covance (CRO) DuPont (AgBio) Vet. diagnostic labs (animal health) Central science lab (biosecurity) IEH labs (food safety) FBI lab services (Forensics) Market size / growth (2011) $xx.xb (~ of total) / ( F CAGR) $xx.xb (~ of total) / ( F CAGR) ~$xx.xb (~ of total) / ( F CAGR) Key trends driving and moderating growth + Continued contribution of ARRA funding spend through Increased awareness of not-for-profit funding alternatives*** - Cutback in funding, given austerity measures in developed countries - Increased uncertainty in funding, given decreased success rate in NIH grant funding (from ~30% to ~20%) Source: * BioPharma includes instrument and reagent purchased by CRO (not price of services charged to Biopharma) ** Centre national de la recherche scientifique (CNRS) in France, National Health Service (NHS) in the U.K. *** Example foundations: HHMI, Gates foundation, Keck / Kavli / Doris Duke foundation) **** Applied market customers adopt technologies xx-xx years after academic customers, but before clinical customers DeciBio analysis 8
9 We used a combination of primary and secondary research to compile data presented in this report Data and analysis Primary research Interviews with 37 experts* 17 academic professors and post-doctoral fellows** from leading institutions worldwide (~60% in the U.S.) 7 lab directors and senior scientists in large Pharma 4 lab directors and senior scientists in small to midsize biotech companies 5 lab directors and scientists in applied markets 4 life science business experts / professionals Interview structure Funding Current and future activity Key players and technologies Trends and unmet needs Secondary research Company financial information 10-K / 10-Q Company presentations Press releases Company technical information Company website Company publications and posters Company technical sheets Other sources PubMed Peer-reviewed publications and scientific posters Government reports and databases (e.g., NIH reporter) Healthcare conferences (e.g., JP Morgan, Cowen) We built a bottom-up market model by technology; growth rates obtained from interviewee feedback and secondary research guidance were triangulated with the reality reflecting the current funding environment*** Source: * Overall: 23 interviews in the U.S., 10 in Europe and 4 in the rest of the world; ** 5 post-doctoral fellows *** All discussion started with discussion of the funding environment, and interviewees were asked to reassess future technology usage based on their current funding (e.g., what would they stop doing to fund new large scale RNA-Seq projects) DeciBio analysis 9
10 While many technologies discussed in this report were invented within the last ~30 years, a few methods have been used for more than a century Key events for selected technologies discussed in this report 1590: Microscopy 1873: Fluorescent microscopy Invention 1971: ELISA Invention 1984: Label free (SPR) Biacore founded 1975: Western blot Invention 1986: qpcr Invention 1990: microarrays Invention 1995: dpcr Invention 1999: NGS 454 Life Sciences founded < : Flow cytometry Invention 1983: PCR Invention 1995: Multiplex techs Luminex founded 1996: HCI** Cellomics founded 1900: Chromatography 1919: Mass spectroscopy 1931: Electron microscopy 1945: NMR Invention 1986: Mag beads Dynal founded 1986: Sample prep First plasmid kit* 2000: Prot. microarrays Invention Genomics Proteomics Cell biology Other techs Source: * Introduced by Qiagen; ** High content imaging DeciBio analysis 10
11 Agenda Introduction Executive summary Pure genomics tools Pure proteomics tools Cell biology tools Other analytical technologies Other supplies and technologies Appendix 11
12 As defined in this report, the worldwide life science research tools market is expected to grow at p.a. from ~$xx.xb in 2011 to reach ~$xx.xb in 2016 WW life sciences research tools market by category ( F)* Billions of dollars $50 Dummy data $ $ $ $ $ E 2016F Other technologies Other analytical techs Source: Cell biology Pure genomics Pure proteomics CAGR ( ) ( F) [Next generation sequencing] is poised to become the key technology to deliver on the promise of personalized medicine and to drive the routine use of genomic[s] in medical practice [ ] We believe that in a not very distant future, infants will be sequenced at birth [ ] And as we get down toward $1,000 genome, we think that, that opportunity is going to break wide open and generate [revenue] greater than the loss from the pricing changes - CEO, Illumina (Earnings call, 02/07/2012) * Excluding IVD (sales of IVD/510(k)/CE-marked tests [see Appendix]) DeciBio analysis Category Other technologies Other analytical technologies Cell biology Pure proteomics technologies Pure genomics technologies Selected Technologies 2011E Market size ($B) CAGR Lab supplies xx xx Glassware xx xx Automation xx xx Sample preparation xx xx LIMS xx xx Magnetic beads xx xx Liquid chromato. xx xx Mass spectrometry xx xx Structural analysis xx xx In vivo study xx xx Spectroscopy xx xx Multiplex techs xx xx Label free techs xx xx Discovery services xx xx Basic reagents xx xx Flow cytometry xx xx Transfection & electroporation xx xx Media and sera xx xx Microscopy xx xx Cell culture equipment xx xx Whole cell analysis xx xx Cells and tissues xx xx High content imaging xx xx Protein isolation & analysis xx xx Protein production xx xx ELISA xx xx Western blots xx xx Protein microarrays xx xx qpcr xx xx Microarrays xx xx NGS / 3GS xx xx PCR xx xx CE Sequencing xx xx Molecular biology xx xx Digital PCR xx xx Attractive Neutral Unattractive
13 And growth in applied markets in the U.S. and abroad, given low- to midsingle digit growth from academic and BioPharma customers WW life sciences research tools market by end customer ( F)* Billions of dollars $50 Dummy data $40 $30 $20 $10 $ E 2016F Applied markets Biopharma Academia CAGR ( ) ( F) We saw a significant slowdown in [the academic and government] market in Q3 [2011, due to] uncertainty around the future of NIH budgets, as well as the budget crisis in many European countries [ ] Turning to Pharma and Biotech, we had a very strong finish to the year in this customer set driven by demand in research, development and manufacturing. In research applications, we had solid momentum in mass spectrometry. [ ] Demand from industrial-implied markets generated strong growth in both revenues and bookings during [Q4 2011]. - CEO, Thermo Fisher (Earnings call, 02/01/2012) Academic and Biopharma customers have experienced a significant decrease in R&D funding during the 2009 recession Key LS technologies used in applied markets include Applied markets tend to be xx-xx years behind academic customers with regards to technology adoption Applied markets considered in this study include: AgBio, Animal health, Biosecurity, Environmental testing, Food safety, Forensics, Human identification, Pharma QA/QC Source: * Excluding IVD (sales of IVD/510(k)/CE-marked tests [see Appendix]) DeciBio analysis 14
14 In the technology life cycle, instruments generate revenue first, followed by increased reagent pull-through as the instrument installed based expands WW life sciences research tools market by product type ( F)* Billions of dollars $50 Dummy data $40 $30 $20 $10 $- Source: E 2016F Instruments, service contracts and Software Reagents, consumables and Services CAGR ( ) ( F) The instrument:reagent split is an interesting question. What we ve seen in recent years is many companies being willing to compromise on margins for instruments in order to increase placement [ ] Once instruments are placed, reagent pull through can be significant. For instance, just a few years ago, Illumina reported >$500K per year per placed microarray reader, and this number is in the $300K range for their high-end sequencing platforms. And that s not including additional revenues for instrument service contracts - Director, top tier research tool company * Excluding IVD (sales of IVD/510(k)/CE-marked tests [see Appendix]) DeciBio analysis Key analytical Instruments include: Liquid chromatographs (~$xxxm) Mass spectrometers (~$xxxm) Structural analysis instruments, including electron microscopes, NMR and X-ray systems (~$xxxm) Basic instruments, such as balances, pipettes and centrifuges (~$xxxm) Lab automation instruments (~$xxxm) Spectrometers (~$xxxm) Optical and fluorescent microscopes (~$xxxm) NGS sequencers (~$xxxm) qpcr thermal cyclers (~$xxxm) Flow cytometers (~$xxxm) Key reagents include qpcr assays (~$xxxm) Cell based assay discovery services (~$xxxm) Basic cell biology reagents (~$xxxm) Microarray chips (~$xxxm) Protein isolation and analysis reagents (~$xxxm) Media and sera (~$xxxm) Sample preparation kits and reagents (~$xxxm) Cell culture equipment (~$xxxm) ELISA plates (~$xxxm) Molecular biology reagents (~$xxxm) 15
15 Agenda Introduction Executive summary Pure genomics tools Pure proteomics tools Cell biology tools Other analytical technologies Other supplies and technologies Appendix 19
16 The worldwide LS research tools genomics market is expected to grow at p.a., driven by strong double-digit growth in next generation sequencing WW life sciences research tools genomics market ( F)* Billions of dollars $12 $10 $8 $6 $4 $2 $ E 2016F digital PCR Molecular biology CE Sequencing PCR NGS / 3GS Microarrays qpcr Group Technology Key application PCR Sequencing PCR qpcr dpcr NGS / 3GS CE sequencing Standard amplification CAGR ( ) ( F) Gene expression analysis, genotyping Same as qpcr, with lower detection limit de novo sequencing, resequencing, RNA-Seq Sequence validation Other Microarrays Gene expression analysis, genotyping Drivers and moderators Key trends End customers Academic customers (~) BioPharma (~) Applied markets (~) Key competitors Life technologies, Roche, Illumina, Bio-Rad Source: * Excluding IVD (sales of IVD/510(k)/CE-marked tests [see Appendix]) ** Availability of bench sequencers (e.g., Life Technologies, Illumina) with lower throughput than standard NGS platforms DeciBio analysis 20
17 The ~$x.xb qpcr market is expected to grow at p.a., driven by xxx and xxx WW life sciences qpcr market ( F)* Millions of dollars $70 Dummy data $60 $50 $40 $30 $20 $10 $ E 2016F Instruments Reagents CAGR ( ) ( F) Additional growth offset by patent expirations and availability of cheaper alternatives to TaqMan Drivers and moderators Key trends Description and applications: quantitative Polymerase Chain Reaction (qpcr) is a variation of PCR that utilizes reagents (e.g., primers, DNA binding dyes) that are fluorescently tagged in order to follow the reaction in real time. This method is used primarily for genotyping applications mrna levels quantification or nucleic acid monitoring (e.g., viral load analysis). Due to his more quantitative nature, this method has been used widely in clinical settings (not included in market size above; see appendix). Despite the availability of NGS or microarrays, qpcr continues to be used a discovery tool in hypothesis driven experiments [ ] However, people think about it more as a validation tool downstream of microarrays or NGS Source: - Assistant Professor, Harvard Medical School * Excludes MDx revenues; see Appendix; Company 10-Ks and press releases, DeciBio interviews and analysis End customers Academic customers (~), BioPharma (~), Applied markets (~) Key competitors Life technologies (Applied Biosystems), Roche, Bio- Rad, xxx, xxx, xxx 21
18 Agenda Introduction Executive summary Pure genomics tools Pure proteomics tools Cell biology tools Other analytical technologies Other supplies and technologies Appendix 28
19 The ~$xxm ELISA market is expected to grow at p.a., driven by continued conversion of competitive to sandwich ELISA, as well as adoption of kits WW life sciences ELISA market ( F)* Millions of dollars $70 Dummy data $60 $50 $40 $30 $20 $10 $- Source: E 2016F Instruments Reagents CAGR ( ) ( F) An increasing number of companies offer ELISA kits, and quality is improving. We don t bother home brewing anymore. We recently tried CST PathScan kits and the results are extremely reproducible Description and applications: Enzyme-linked immunosorbent assay (ELISA), is an analytical biochemistry assay that uses reagents (often an antibody) attached to a plate to detect the presence of a substance (often a protein) in a sample. ELISA is a common tool and is used in applications ranging from basic research (especially for protein quantification), quality control (detection of contaminants) all the way to clinical diagnostics (not included in market numbers above) - Associate Professor, UCSD * Excluding IVD (sales of IVD/510(k)/CE-marked tests [see Appendix]); Company 10-Ks and press releases, DeciBio interviews and analysis Drivers and moderators Key trends End customers Academic customers (~) BioPharma (~) Applied markets () Key competitors Life Technologies, Techne (R&D Systems), BD Biosciences, Millipore, Cell Signaling Technologies 32
20 Major abbreviations used in this report 3GS: Third generation sequencing AgBio: Agricultural biotechnology ARRA: American Recovery and Reinvestment Act ATCC: American Type Culture Collection BRIC: Brazil, India, China CE Sequencing: Capillary electrophoresis sequencing CAGR: Compound annual growth rate CGH: Comparative genomic hybridization CNV: Copy number variation COLD PCR: Co-amplification at lower denaturation temperature-pcr CMO: Contract manufacturing organization CRO: Contract research organization Dx: Diagnostics ELISA: Enzyme-linked immunosorbent assay GPCR: G protein-coupled receptors HCI: High content imaging HHMI: Howard Hughes Medical Institute HLA: Human leukocyte antigen HPLC: High-performance liquid chromatography HPV: Human papillomavirus HTS: High throughput screening IVD: in vitro diagnostic KO: Knock-out LGC: Large genome center LIMS: Laboratory information management system LS: Life sciences MALDI-TOF: Matrix-assisted laser desorption/ionization-time of flight mirna: micrornas MDx: Molecular diagnostics MHC: Major histocompatibility complex MRSA: Methicillin-resistant Staphylococcus aureus NA: Nucleic acid ncrna: non-coding RNAs NGS: Next generation sequencing NIH: National institute of Health NMR: Nuclear magnetic resonance OEM: Original equipment manufacturer p.a.: Per annum PCR: Polymerase chain reaction PGM: Personal genome machine Pharma QA/QC: Pharma quality assurance and quality control POC: Point-of-care QA / QC: Quality assurance / quality control qpcr: quantitative PCR R&D: Research and Development RNA: Ribonucleic acid ROW: Rest of world RUO: Research use only SNP: Single nucleotide polymorphism SPR: Surface plasmon resonance TBD: To-be-determined UCSD: University of California San Diego UCSF: University of California San Francisco UHTS: Ultra-high throughput screening WW: Worldwide 72
21 If interested in this report, consider the following DeciBio reports Find related DeciBio reports on our website: Next Generation Sequencing: Market Size, Segmentation, Growth and Trends by Provider ( Fluidigm Due Diligence: Company Profile, SWOT Analysis and Market Opportunity ( Molecular Diagnostics: Market Size, Segmentation, Growth and Opportunities ( Molecular Diagnostics: Market Size, Segmentation, Growth and Opportunities ( Qiagen Due Diligence: Company Profile, SWOT Analysis and Market Opportunity ( 73
22 Disclosures Information contained in this market report is believed to be reliable at the time of publication. However, DeciBio does not warrant its accuracy or completeness. Opinions, estimates and other information constitute the judgment of DeciBio, and can be subject to change without notice. DeciBio is not soliciting any action based on the information contained in this report. This report is provided for informational purposes only and should not be construed as a call for action. DeciBio and its collaborators may own equity and/or securities related to any company cited in this report, and engage in transactions inconsistent with this report. This report and any access to it are intended to the buyer only. This report is published by DeciBio, LLC. All rights reserved. Reproduction or redistribution of this report in any form is prohibited without the prior consent of DeciBio, LLC. This report may contain digital controls and custom watermarks for tracking purposes. Please inquire about site license pricing for your institution by contacting admin@decibio.com before sharing this document. Gold edition 74
Single Cell Genomics (SCG): Market Size, Segmentation, Growth, Competition and Trends ( )
Single Cell Genomics (SCG): Market Size, Segmentation, Growth, Competition and Trends (2013-2021) May, 2017 3 rd Edition Information contained in this market report is believed to be reliable at the time
More informationNext Generation Sequencing (NGS) Market Size, Growth and Trends ( )
Next Generation Sequencing (NGS) Market Size, Growth and Trends (2014-2020) July, 2017 4 th edition Information contained in this market report is believed to be reliable at the time of publication. DeciBio
More informationMolecular Diagnostics: Market Segmentation and Opportunities
Molecular Diagnostics: Market Segmentation and Opportunities October 2010 This market report is published by DeciBio, LLC. All rights reserved. Reproduction or redistribution of this report in any form
More informationTECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298
DIAGNOSTICS BUSINESS ANALYSIS SERIES: TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 By ADAMS BUSINESS ASSOCIATES March 2017. March 2017 ABA 298 1 Technologies, Products & Services
More informationGENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE)
TriMark Publications April 2007 Volume: TMRGER07-0401 GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS
More informationGenomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Increasing usage of novel genomics techniques and tools, evaluation of their benefit to patient outcome and focusing
More informationincluding, but not limited to:
*This Section is part of the original Request for Proposal # P08 080. The Contractor should provide the following eligible Scientific Biomedical Research Equipment, Reagents & Supplies including, but not
More information2100 Bioanalyzer. Overview & News. Ralph Beneke Dec 2010
2100 Bioanalyzer Overview & News Ralph Beneke Dec 2010 RNA QC in Gene Expression Workflows Cited in over 10,000 peer-reviewed papers RIN is the industry standard for RNA QC For any size and at low sample
More informationQIAGEN Sample & Assay Technologies From Discovery to Patient
QIAGEN From Discovery to Patient New York, February 14 QIAGEN 2008 Analyst & Investor Day Peer Schatz, CEO -7- Forward Looking Statements Safe Harbor Statement: Certain of the statements contained in this
More informationIMMUNOASSAY MARKET. Global Forecast to MarketsandMarkets
IMMUNOASSAY MARKET [Technology (Enzyme, Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Application (Infectious Diseases, Cancer, Endocrinology, Cardiology), End-Users (Hospitals,
More informationAxygen AxyPrep Magnetic Bead Purification Kits. A Corning Brand
Axygen AxyPrep Magnetic Bead Purification Kits A Corning Brand D Sample Prep Solutions for Genomics Obtaining Pure Nucleic Acids from Your Sample is Precious The purification of high quality DNA is the
More informationPROTEOMICS: TECHNOLOGIES AND GLOBAL MARKETS. BIO034C May John Bergin Project Analyst ISBN:
PROTEOMICS: TECHNOLOGIES AND GLOBAL MARKETS BIO034C May 2013 John Bergin Project Analyst ISBN: 1-56965-403-4 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301 www.bccresearch.com
More informationPage 1. AMPTask Force on MLS Molecular Pathology Curriculum Dear Molecular Diagnostics Laboratory Manager,
AMPTask Force on MLS Molecular Pathology Curriculum Dear Molecular Diagnostics Laboratory Manager, Recently the Association for Molecular Pathology (AMP) has decided to develop a suggested curriculum in
More informationBio-Pharma: China A Look at The FUTURE: 4 th & 5 th Generation Global Strategies
Global Strategy Global Challenges Executable Solutions Bio-Pharma: China 2010-2020 A Look at The FUTURE: 4 th & 5 th Generation Global Strategies France Houdard Managing Director January 2010 Table of
More informationTecan Group 34 th Annual J.P. Morgan Healthcare Conference DR. DAVID MARTYR, CEO JANUARY 14, 2016 SAN FRANCISCO, USA
Tecan Group 34 th Annual J.P. Morgan Healthcare Conference DR. DAVID MARTYR, CEO JANUARY 14, 2016 SAN FRANCISCO, USA Safe Habor Statement All statements in this presentation not referring to historical
More informationMolecular Diagnostics
Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R
More informationUBS Global Life Sciences Conference
September 21, 2010 UBS Global Life Sciences Conference Tecan Group AG Thomas Bachmann, CEO September 21, 2010 / p2 / UBS Global Life Sciences Conference Introducing Tecan Provider of instruments and workflow-solutions
More informationGENOMICS WORKFLOW SOLUTIONS THAT GO WHERE THE SCIENCE LEADS. Genomics Solutions Portfolio
GENOMICS WORKFLOW SOLUTIONS THAT GO WHERE THE SCIENCE LEADS Genomics Solutions Portfolio WORKFLOW SOLUTIONS FROM EXTRACTION TO ANALYSIS Application-based answers for every step of your workflow Scientists
More informationPAXgene Blood DNA PAXgene Blood DNA Tube (IVD) for clinical use PAXgene Blood DNA System (RUO) for research use. Explore more at
PAXgene Blood DNA PAXgene Blood DNA Tube (IVD) for clinical use PAXgene Blood DNA System (RUO) for research use Explore more at www.preanalytix.com Situation The composition, amount, quality and integrity
More informationNon Deal Roadshow - Europe
Non Deal Roadshow - Europe 2015 May Analyst Meeting February/March 2016 The world leader in serving science The world leader in serving science Non-GAAP Measures This presentation contains certain financial
More informationThe Comprehensive Report
Improved Screening, Adapted Technologies and Enhanced Assays The Comprehensive Report Presented by HighTech Business Decisions 3150 Almaden Expressway, Suite 222, San Jose, CA 95118 Tel: (408) 978-1035
More informationFrom Resilience To Growth:
From Resilience To Growth: Mapping a New Direction for Life Sciences & Medical Devices Attorney Advertising Prior results do not guarantee a similar outcome Models used are not Mapping the Way: Opportunities
More informationSNP GENOTYPING WITH iplex REAGENTS AND THE MASSARRAY SYSTEM
SNP GENOTYPING Accurate, sensitive, flexible MassARRAY System SNP GENOTYPING WITH iplex REAGENTS AND THE MASSARRAY SYSTEM Biomarker validation Routine genetic testing Somatic mutation profiling Up to 400
More informationDedicated to Molecular Diagnostics
Dedicated to Molecular Diagnostics For Europe Sample & Assay Technologies QIAGEN s growing role in molecular diagnostics At QIAGEN, one of our key goals is to support clinical decision-making and improve
More informationPrimerdesign Ltd. High risk Human Papillomavirus. Multiplex screening kit. genesig kit. 100 tests. For general laboratory and research use only
Primerdesign Ltd High risk Human Papillomavirus Multiplex screening kit genesig kit 100 tests For general laboratory and research use only 1 Introduction to Human Papillomavirus Papillomaviruses are a
More informationDeveloping an Accurate and Precise Companion Diagnostic Assay for Targeted Therapies in DLBCL
Developing an Accurate and Precise Companion Diagnostic Assay for Targeted Therapies in DLBCL James Storhoff, Ph.D. Senior Manager, Diagnostic Test Development World Cdx, Boston, Sep. 10th Molecules That
More informationMicrobial Metabolism Systems Microbiology
1 Microbial Metabolism Systems Microbiology Ching-Tsan Huang ( 黃慶璨 ) Office: Agronomy Hall, Room 111 Tel: (02) 33664454 E-mail: cthuang@ntu.edu.tw MIT OCW Systems Microbiology aims to integrate basic biological
More informationQIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd
QIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd 1 Our current NGS & Bioinformatics Platform 2 Our NGS workflow and applications 3 QIAGEN s
More informationUF Center for Pharmacogenomics. Explanation of Services. UF Center for Pharmacogenomics Services
UF Center for Pharmacogenomics Explanation of Services Services are provided either as a price per sample or price per project, depending on the specific needs of the researcher. Basic a la carte services,
More informationHuman Papillomavirus 16
TM Primerdesign Ltd Human Papillomavirus 16 E6 gene genesig Standard Kit 150 tests For general laboratory and research use only 1 Introduction to Human Papillomavirus 16 Papillomaviruses are a diverse
More informationGenetics Lecture 21 Recombinant DNA
Genetics Lecture 21 Recombinant DNA Recombinant DNA In 1971, a paper published by Kathleen Danna and Daniel Nathans marked the beginning of the recombinant DNA era. The paper described the isolation of
More informationJP Morgan Global Healthcare Conference
JP Morgan Global Healthcare Conference January 12, 2016 Robert Friel, Chairman and CEO Factors affecting future performance & non-gaap financial measures This presentation contains "forward-looking" statements
More informationBio-Analytical Measurement Business Briefing
Bio-Analytical Measurement Business Briefing 58 th Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy McCormick Place Chicago, Illinois February 26, 2007 Page 1 Safe-Harbor Statement
More informationBR-10455A. Automated Multiplexed Gene Expression Profiling Process Solutions. Multiplex Quantitative High-throughput
BR-10455A Automated Multiplexed Gene Expression Profiling Process Solutions Multiplex Quantitative High-throughput As a scientist, you understand the challenges of working with limited amounts of sample,
More informationResearch and Innovation in Drug Discovery and Diagnostics
INTERNATIONAL CONFERENCE Intellectual Property and Health Innovation Challenges for the future April 28, 2014, Athens, Greece Research and Innovation in Drug Discovery and Diagnostics Alexander Pintzas,
More informationMOLECULAR DIAGNOSTICS. AIT Austrian Institute of Technology GmbH Center for Health & Bioresources
MOLECULAR DIAGNOSTICS AIT Austrian Institute of Technology GmbH Center for Health & Bioresources AIT AUSTRIAN INSTITUTE OF TECHNOLOGY OWNERSHIP STRUCTURE 49,54% FEDERATION OF AUSTRIAN INDUSTRIES 50,46%
More informationDNA Workflow. Marine Biological Laboratory. Mark Bratz Applications Scientist, Promega Corporation. August 2016
DNA Workflow Marine Biological Laboratory Mark Bratz Applications Scientist, August 2016 Scientific Applications Support Mission Realize customer driven applications of Promega technologies to enhance
More informationMagSi Beads. Magnetic Silica Beads for Life Science and Biotechnology study
MagSi Beads Magnetic Silica Beads for Life Science and Biotechnology study MagnaMedics Diagnostics B.V. / Rev. 9.2 / 2012 Wide range of products for numerous applications MagnaMedics separation solutions
More informationHuman Papillomavirus 16
TM Primerdesign Ltd Human Papillomavirus 16 E6 gene genesig Advanced Kit 150 tests For general laboratory and research use only 1 Introduction to Human Papillomavirus 16 Papillomaviruses are a diverse
More informationM. tuberculosis_mpb64/is611. genesig Advanced Kit. 150 tests. Primerdesign Ltd. For general laboratory and research use only
TM Primerdesign Ltd M. tuberculosis_mpb64/is611 0 genesig Advanced Kit 150 tests For general laboratory and research use only 1 Introduction to M.tuberculosis_MPB64/IS6110 2 Specificity MAX MIN The Primerdesign
More informationCase Studies on ultra-sensitive immunoanalytics based on Imperacer (Immuno-PCR) in clinical settings. Jan Detmers, Ph.D. (Chimera Biotec GmbH)
Case Studies on ultra-sensitive immunoanalytics based on Imperacer (Immuno-PCR) in clinical settings. Jan Detmers, Ph.D. (Chimera Biotec GmbH) Agenda 1.Overview Platforms 2.Immuno-PCR (Imperacer ) Technology
More informationEGFR T790M mutation mutation detection by quantitative allele specific amplification (quasa) EGFR (T790M)
Primerdesign TM Ltd EGFR T790M mutation mutation detection by quantitative allele specific amplification (quasa) EGFR (T790M) 50 tests For general laboratory and research use only 1 Contents Introduction
More informationHuman Papillomavirus 52 and 52b
Techne qpcr test Human Papillomavirus 52 and 52b E6 gene 150 tests For general laboratory and research use only 1 Introduction to Human Papillomavirus 52 and 52b Papillomaviruses are a diverse group of
More informationE2ES to Accelerate Next-Generation Genome Analysis in Clinical Research
www.hcltech.com E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution
More informationTexas A&M University-Corpus Christi CHEM4402 Biochemistry II Laboratory Laboratory 4 - Polymerase Chain Reaction (PCR)
Texas A&M University-Corpus Christi CHEM4402 Biochemistry II Laboratory Laboratory 4 - Polymerase Chain Reaction (PCR) Progressing with the sequence of experiments, we are now ready to amplify the green
More informationNext Generation Sequencing (NGS)
Next Generation Sequencing (NGS) Fernando Alvarez Sección Biomatemática, Facultad de Ciencias, UdelaR 1 Uruguay Montevide o 3 TANGO World Champ 1930 1950 (Maraca 4 Next Generation Sequencing module Next
More informationIntroduction to BioMEMS & Medical Microdevices DNA Microarrays and Lab-on-a-Chip Methods
Introduction to BioMEMS & Medical Microdevices DNA Microarrays and Lab-on-a-Chip Methods Companion lecture to the textbook: Fundamentals of BioMEMS and Medical Microdevices, by Prof., http://saliterman.umn.edu/
More informationQuantifiler Human DNA Quantification Kit Quantifiler Y Human Male DNA Quantification Kit
Product Bulletin Human Identification Quantifiler Human DNA Quantification Kit Quantifiler Y Human Male DNA Quantification Kit The Quantifiler kits produce reliable and reproducible results, helping to
More informationNon-Organic-Based Isolation of Mammalian microrna using Norgen s microrna Purification Kit
Application Note 13 RNA Sample Preparation Non-Organic-Based Isolation of Mammalian microrna using Norgen s microrna Purification Kit B. Lam, PhD 1, P. Roberts, MSc 1 Y. Haj-Ahmad, M.Sc., Ph.D 1,2 1 Norgen
More informationM. tuberculosis_mpb64/is61 10 genesig Standard Kit
TM Primerdesign Ltd M. tuberculosis_mpb64/is61 10 genesig Standard Kit 150 tests For general laboratory and research use only 1 Introduction to M.tuberculosis_MPB64/IS6110 2 Specificity MAX MIN The Primerdesign
More information36 th Annual JP Morgan Healthcare Conference. January 11 th, 2018
36 th Annual JP Morgan Healthcare Conference January 11 th, 2018 1 Forward-looking Statements This presentation and the accompanying oral commentary contain forward -looking statements that involve risks,
More informationPathogen Test Methods What s New in Methodology and Detection Limits
Pathogen Test Methods What s New in Methodology and Detection Limits Debbie Cherney Cherney Microbiological Services, Ltd WAFP Workshop June 12, 2013 I m going to take us on a trip Hold on tight, don t
More informationTamiflu resistance detection kit
Tamiflu resistance detection kit H1N1 (H275Y) genesig real-time PCR mutation detection/allelic discrimination kit 150 tests For general laboratory and research use only genesig Tamiflu resistance detection
More informationCELL-BASED ASSAYS: TECHNOLOGIES AND GLOBAL MARKETS
CELL-BASED ASSAYS: TECHNOLOGIES AND GLOBAL MARKETS BIO080B April 2014 Usha Nagavarapu Project Analyst ISBN: 1-56965-794-7 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationJob Title: Cell Culture Technician (open June 1 through Oct 31, 2016)
Rockland Immunochemicals Inc. is recognized as one of the world's leading manufacturers and suppliers of immunochemical reagents for basic research and discovery. Rockland Immunochemicals provides reagents
More informationInnovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing
Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing Overview Serving biotech and pharma community since 1998 Proven track record of advancing small molecules from
More informationHow Advances in Molecular Diagnostics Will Further Drive Consolidation of All Lab Testing. Executive War College 2013 New Orleans, LA
How Advances in Molecular Diagnostics Will Further Drive Consolidation of All Lab Testing Executive War College 2013 New Orleans, LA Discussion Points What s driving consolidation? What is the relationship
More informationAcinetobacter baumannii
TM Primerdesign Ltd Acinetobacter baumannii hypothetical protein sequence gene genesig Standard Kit 150 tests For general laboratory and research use only 1 Introduction to Acinetobacter baumannii Acinetobacter
More informationMOLECULAR DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS. BIO063B March Jon Evans Project Analyst ISBN:
MOLECULAR DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS BIO063B March 2013 Jon Evans Project Analyst ISBN: 1-56965-134-5 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
More informationLecture #1. Introduction to microarray technology
Lecture #1 Introduction to microarray technology Outline General purpose Microarray assay concept Basic microarray experimental process cdna/two channel arrays Oligonucleotide arrays Exon arrays Comparing
More informationUBS Global Life Sciences Conference
September 20, 2011 UBS Global Life Sciences Conference Tecan Group AG Dr. Rudolf Eugster, CFO September 20, 2011 / p2 / UBS GLSC Contents Introducing Tecan Strategic Growth Drivers Financials H1 2011 &
More informationUnited States Lateral Flow Assay Market Report 2017
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > United States Lateral Flow Assay Market Report 2017 United States Lateral Flow Assay Market Report 2017 Publication
More informationBIOMARKERS - ADVANCED TECHNOLOGIES AND GLOBAL MARKET ( )
BIOMARKERS - ADVANCED TECHNOLOGIES AND GLOBAL MARKET (2009-2014) R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r
More informationAgilent Technologies First Quarter Fiscal 2017 Conference Call Prepared Remarks
Agilent Technologies First Quarter Fiscal 2017 Conference Call Prepared Remarks ALICIA RODRIGUEZ Thank you, and welcome everyone to Agilent's First Quarter Conference Call for Fiscal Year 2017. With me
More informationAgilent Genomics Software Future Directions
Agilent Genomics Software Future Directions Michael Rosenberg, PhD Director, Genomics Software Agilent: A Focused Measurement Company Serving Diverse End Markets Electronic Measurement 2008 Revenue: $3.6
More informationThe China In Vitro Diagnostics (IVD) Market has been analyzed from 4 View Points:
China In Vitro Diagnostics (IVD) Market - Overview China In-Vitro Diagnostics (IVD) market is among the fastest growing in the world. It is anticipated that China IVD market will more than triple by 2020
More informationStaphylococcus aureus
TM Primerdesign Ltd Staphylococcus aureus FEMB gene (chromosomal gene) genesig Standard Kit 150 tests For general laboratory and research use only 1 Introduction to Staphylococcus aureus Staphylococcus
More informationIQ4I Research. and Consultancy. Research and Consultancy v4023/ Publisher Sample
IQ4I Research and Consultancy http://www.marketresearch.com/iq4i Research and Consultancy v4023/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday -
More informationJefferies Global Health Care Conference. June 1, 2015
Jefferies Global Health Care Conference June 1, 2015 Forward-Looking Statements This presentation may contain projections, estimates and other forwardlooking statements that involve a number of risks and
More informationBruker drives profitable growth by enabling breakthrough discoveries & development of new applications that improve the quality of human life
Bruker drives profitable growth by enabling breakthrough discoveries & development of new applications that improve the quality of human life Innovation with Integrity BRUKER CORPORATION Safe Harbor Statement
More informationQuantStudio Dx Real-Time PCR Instrument
QuantStudio Dx Real-Time PCR Instrument Behind every diagnosis, there is a promise You believe in molecular medicine. So do we. We are committed to providing you with comprehensive solutions that help
More informationHuman Herpes Virus 1 (Herpes simplex type 1)
TM Primerdesign Ltd Human Herpes Virus 1 (Herpes simplex type 1) Capsid assembly and DNA maturation gene genesig Standard Kit 150 tests For general laboratory and research use only 1 Introduction to Human
More informationWebinar July 9, Noon. The Essentials of Diagnostics: Introduction to Molecular Diagnostics
Webinar July 9, 2013 12 Noon The Essentials of Diagnostics: Introduction to Molecular Diagnostics 1 DxInsights mission is to educate healthcare stakeholders on the power and value of diagnostics and their
More informationHow to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations. The complete guide to developing or expanding your lab
How to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations The complete guide to developing or expanding your lab Includes step-by-step plans for basic and full-service MDx
More informationSeparation Systems for Commercial Biotechnology. Shalini S. Dewan. Report # BIO011G
Separation Systems for Commercial Biotechnology Shalini S. Dewan Report # BIO011G Table of Contents Chapter 1 Introduction... 1 Introduction... 2 Study goals and objectives... 2 Reasons for doing this
More informationIDEAL TM Spike-In RNA Kit. Individual Assays Principle, Workflow and Protocol
IDEAL TM Spike-In RNA Kit Individual Assays Principle, Workflow and Protocol Table of Contents Content Page Working Principle 3 Kit Contents & Storage 4 Additional Equipment and Compatibility 5 Workflow
More informationThis is a licensed product of Ken Research and should not be copied
1 TABLE OF CONTENTS 1. India In-Vitro Diagnostics Market Introduction Market Overview Growth Drivers Constraints Regulatory Framework and Accreditation 2. India In-Vitro Diagnostics Market Size by Revenues,
More informationIntroducing a new generation of affordable choices from the leader in real-time PCR. Applied Biosystems 7500 Fast Real-Time PCR System
7300/7500 Real-Time PCR Systems Introducing a new generation of affordable choices from the leader in real-time PCR. Applied Biosystems 7500 Real-Time PCR System Applied Biosystems 7500 Fast Real-Time
More informationRoche Molecular Biochemicals Technical Note No. LC 10/2000
Roche Molecular Biochemicals Technical Note No. LC 10/2000 LightCycler Overview of LightCycler Quantification Methods 1. General Introduction Introduction Content Definitions This Technical Note will introduce
More informationGENOMICS WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE)
TriMark Publications May 2008 Volume: TMRGEN08-0515 GENOMICS WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS 1. Introduction
More informationDengue Virus subtypes 1, 2, 3 and 4 (Multiplex kit)
Primerdesign TM Ltd Dengue Virus subtypes 1, 2, 3 and 4 (Multiplex kit) genesig advanced kit 100 tests For general laboratory and research use only 1 Contents Introduction to Dengue Virus 3 Specificity
More informationmmu-mir-200a-3p Real-time RT-PCR Detection and U6 Calibration Kit User Manual MyBioSource.com Catalog # MBS826230
mmu-mir-200a-3p Real-time RT-PCR Detection and U6 Calibration Kit User Manual Catalog # MBS826230 For the detection and quantification of mirnas mmu-mir-200a-3p normalized by U6 snrna using Real-time RT-PCR
More informationHelicobacter pylori. genesig Standard Kit. RNA polymerase beta-subunit (rpob) gene. 150 tests. Primerdesign Ltd
TM Primerdesign Ltd Helicobacter pylori RNA polymerase beta-subunit (rpob) gene genesig Standard Kit 150 tests For general laboratory and research use only 1 Introduction to Helicobacter pylori Helicobacter
More informationJEFFERIES 2015 GLOBAL HEALTHCARE CONFERENCE JUNE 3, 2015 NACHUM HOMI SHAMIR PRESIDENT AND CHIEF EXECUTIVE OFFICER
JEFFERIES 2015 GLOBAL HEALTHCARE CONFERENCE JUNE 3, 2015 NACHUM HOMI SHAMIR PRESIDENT AND CHIEF EXECUTIVE OFFICER SAFE HARBOR STATEMENT Certain statements made during the course of this presentation may
More informationEpstein Barr Virus (Human Herpes virus 4)
TM Primerdesign Ltd Epstein Barr Virus (Human Herpes virus 4) nonglycosylated membrane protein (BNRF1) gene genesig Standard Kit 150 tests For general laboratory and research use only 1 Introduction to
More information35th Annual J.P. Morgan Healthcare Conference
35th Annual J.P. Morgan Healthcare Conference Investor Presentation Nachum Homi Shamir President and Chief Executive Officer January, 2017 Safe Harbor Statement Certain statements made during the course
More informationIntroduction to Bioinformatics and Gene Expression Technologies
Introduction to Bioinformatics and Gene Expression Technologies Utah State University Fall 2017 Statistical Bioinformatics (Biomedical Big Data) Notes 1 1 Vocabulary Gene: hereditary DNA sequence at a
More informationCreating New Business. In a Large Company. Dr. Lee Ng. Business Director. New Business Creation
In a Large Company Business Director New Business Creation Agilent Technologies, Inc. 5301 Steven s Creek Blvd, Santa Clara, CA 95051 lee_ng@agilent.com lee_ng@alum.mit.edu Page 1 Outline Agilent Creating
More informationTaqPath ProAmp Master Mixes
PRODUCT BULLETIN es es Applied Biosystems TaqPath ProAmp Master Mixes are versatile master mixes developed for high-throughput genotyping and copy number variation (CNV) analysis protocols that require
More informationCaMV promoter & NOS terminator detection
Primerdesign TM Ltd GMO event quantification CaMV promoter & NOS terminator detection Detection and quantification of GMO integration events in Soya by real-time PCR 100 tests Kit contents CaMV-GM primer/probe
More informationLeading The Way in Life Science Technologies. Planning Calendar
Leading The Way in Life Science Technologies 2018 Planning Calendar January 1 Reservation: 11/30/17 Material: 12/7/17 l Kinase Assays l Immunotherapy l Stem-Cell Manufacturing Peptalk, January 8 12, San
More informationArachis hypogaea A.hypogaea. genesig Allergen detection Kit. 100 tests. Primerdesign Ltd. For general laboratory and research use only
TM Primerdesign Ltd Arachis hypogaea A.hypogaea genesig Allergen detection Kit 100 tests For general laboratory and research use only 1 Introduction to Arachis hypogaea Peanut (Arachis hypogaea) belongs
More informationSus scrofa Pig genesig Advanced Speciation Kit
TM Primerdesign Ltd Pig genesig Advanced Speciation Kit 100 tests For general laboratory and research use only 1 Principles of the test Real-time PCR This kit provides a method for detecting mitochondrial
More informationCAP Accreditation Checklists 2017 Edition
CAP Accreditation Checklists 2017 Edition The College of American Pathologists (CAP) accreditation checklists contain the CAP accreditation program requirements, developed on more than 50 years of insight
More informationRNA Clean-Up and Concentration Kit Product # 23600, 43200
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com RNA Clean-Up and Concentration Kit Product # 23600, 43200 Product
More informationMassARRAY System MASSARRAY SYSTEM ACCELERATING RESEARCH
SENSITIVITY ACCELERATING RESEARCH SPEED SPECIFICITY ACCURACY No compromise MASSARRAY SYSTEM Genotyping Somatic mutation profiling Methylation analysis Quantitative gene expression and copy number variant
More informationEmerging Focus. Nutrigenomics. Department of Nutritional Sciences Faculty of Life Sciences
Emerging Focus Nutrigenomics Emerging Focus Nutrigenomics The Emerging Focus Nutrigenomics A New Research Group at the of the University of Vienna Overview Nutrigenomics is the study of the response of
More informationDNA Biosensors. Anand Jagota 16 November 2015
DNA Biosensors Anand Jagota 16 November 2015 1 Market, Unmet Needs Worldwide In-vitro diagnostics ~$ 50 Billion and growing Nucleic Acid diagnostics ~$9 Billion Health, Security, Pathogen Detection, etc.
More informationApplied Biosystems Real-Time PCR Rapid Assay Development Guidelines
Applied Biosystems Real-Time PCR Rapid Assay Development Guidelines Description This tutorial will discuss recommended guidelines for designing and running real-time PCR quantification and SNP Genotyping
More informationExpression Array System
Integrated Science for Gene Expression Applied Biosystems Expression Array System Expression Array System SEE MORE GENES The most complete, most sensitive system for whole genome expression analysis. The
More information